Growth Metrics

Insmed (INSM) Depreciation & Amortization (CF) (2016 - 2026)

Insmed's Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $2.9 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 55.82% to $2.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Mar 2026, up 81.91% year-over-year, with the annual reading at $10.4 million for FY2025, 73.33% up from the prior year.
  • Depreciation & Amortization (CF) came in at $2.9 million for Q1 2026, down from $3.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.6 million in Q4 2025 to a low of $851000.0 in Q3 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $1.5 million (2023), against an average of $1.8 million.
  • Year-over-year, Depreciation & Amortization (CF) tumbled 61.97% in 2022 and then skyrocketed 135.66% in 2025.
  • Insmed's Depreciation & Amortization (CF) stood at $2.2 million in 2022, then crashed by 32.43% to $1.5 million in 2023, then rose by 2.85% to $1.5 million in 2024, then surged by 135.66% to $3.6 million in 2025, then fell by 17.93% to $2.9 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Depreciation & Amortization (CF) are $2.9 million (Q1 2026), $3.6 million (Q4 2025), and $2.5 million (Q3 2025).